Fig. 8.

NK cells were activated after MWA of early-stage breast cancer in the clinic. a Schematic illustrating the experimental design for b–h. The percentages of peripheral NK cells (b), CD16+ NK cells (c), NKp46+ NK cells (d), and NKG2A+ NK cells (e) before and 7 days after treatment in the surgery group and MWA group. Serum IL-15 (f), granzyme B (g), and FasL levels (h) before and 7 days after treatment in the surgery group and MWA group. For all panels, data are plotted as the mean ± SD. P values were calculated using the parametric test (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001)